Client Background
Our client pioneers global advancements in healthcare
With a widespread presence across the Americas, Europe, and Asia-Pacific regions, the company is known for its commitment to research and development. The client focuses on breakthrough treatments in areas such as oncology, ophthalmology, and immunology. They are at the forefront of pioneering therapies, utilizing cutting-edge technologies and precision medicine to address unmet medical needs. The client is also deeply invested in sustainability and access to healthcare, aiming to expand patient access to life-saving treatments globally while fostering strong collaborations with healthcare providers and research institutions.
Challenge
Difficulty Identifying Key Competitor Service Differentiators
To strategically position its new immunology drug in the U.S. market, the client sought comprehensive insights into competitor value-added services. This required an in-depth analysis of specialty pharmacy networks supporting competitor drugs, their enhanced service offerings, and the extent of differentiation. Additionally, the study evaluated the presence and functionalities of HCP portals, assessing the depth of resources and support provided. A detailed comparison of co-pay and co-pay debit card programs across immunology drugs was also conducted to identify key variations in patient access and affordability strategies.
Healthark’s role
Delivered Competitive Analysis for Strategic Decision-Making
Healthark collaborated closely with the client to conduct in-depth market research, delivering strategic insights through a structured, multi-phase approach to drive informed decision-making.
- Specialty Pharmacy Network Analysis We conducted an in-depth assessment of approximately 70 drugs, including analogs of the client’s drug, recent launches, and top-performing products from leading manufacturers. Our analysis focused on identifying the presence of Enhanced Specialty Pharmacy networks and the value-added services they offered. Additionally, we mapped the top specialty pharmacies partnered with by key industry players to highlight potential strategic partners for the client. A similar detailed evaluation was performed for leading immunology products to provide a comprehensive competitive landscape.
- HCP Portal Benchmarking & Recommendations We analyzed 15 top drug manufacturers to assess the availability of cross-portfolio, therapeutic area (TA)-based, and brand-specific HCP portals. Each portal was thoroughly examined to identify key features, functionalities, and the primary stakeholders it targeted. Based on these insights, we developed strategic recommendations to help the client optimize their HCP portal by incorporating essential features that enhance engagement and usability.
- Co-Pay Debit Card Analysis We examined approximately 20 leading competitor brands to assess which offered co-pay debit cards. Our analysis mapped the patient journey for co-pay and co-pay debit card registration, evaluating the level of information required, the number of steps involved, and delivery methods. This helped identify potential patient drop-off points and barriers to access. Based on these insights, we developed key recommendations to streamline the client’s co-pay debit card registration process, enhancing patient engagement and retention.
- Insights Synthesis & Strategic Recommendations Our comprehensive analysis of specialty pharmacy networks, HCP portals, and co-pay debit card programs provided key competitive insights to inform the client’s market strategy. We identified best practices in value-added services, key differentiators in HCP portal functionalities, and potential friction points in patient access programs. These findings were compiled into a detailed market landscape report, outlining competitor positioning and opportunities for differentiation. Additionally, we developed a set of strategic recommendations to optimize engagement with HCPs and patients.
Empowering Tomorrow's Healthcare
This case study demonstrates how Healthark’s strategic insights and data-driven solutions supported a leading pharmaceutical company in successfully launching their novel immunology drug. Through a comprehensive analysis of specialty pharmacy networks, HCP portals, and co-pay programs, we delivered actionable insights that helped the client differentiate their services. Our contributions enabled the client to enhance patient and provider engagement, streamline access programs, and make well-informed decisions, ultimately ensuring the drug’s successful positioning in the U.S. market.
Want to learn more about Healthark’s expertise in Growth Advisory? Explore our website or contact us today!
